MedTrace Logo

Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block

NCT03679897 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2018-12-20

No results posted yet for this study

Summary

Infraclavicular brachial plexus block has been used more frequently with the development of high-resolution ultrasound. Compared with peripheral nerve block using landmark technique or nerve stimulator technique, ultrasound-guided peripheral nerve block decreases the required dose of local anesthetics. As the dose of the drug used decreases, the systemic toxic effects of local anesthetics are reduced. However, the decreased dose of the drugs might have influence on the onset time of local anesthetics. Thus, the investigator aimed to evaluated the onset time of the two equipotent local anesthetics, 0.375% ropivacaine and 0.25% levobupivacaine.

Conditions

  • Regional Anesthesia

Interventions

DRUG

Ropivacaine solution

ultrasound-guided infraclavicular brachial plexus block with 0.375% ropivacaine solution

DRUG

Levobupivacaine solution

ultrasound-guided infraclavicular brachial plexus block with 0.25% levobupivacaine solution

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Won Uk Koh, M.D., Ph.D. · University of Ulsan, College of Medicine, Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-18
Primary Completion
2018-12-07
Completion
2018-12-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03679897 on ClinicalTrials.gov